Thomas Malley Insider Trading $BGNE BeiGene, Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas Malley.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas Malley. Thomas Malley is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Cougar Biotechnology, Inc. ($CGRB) and Director in Kura Oncology, Inc. ($KURA) and Director in OvaScience, Inc. ($OVAS) and Director in BeiGene, Ltd. ($BGNE) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).

Thomas Malley in BeiGene, Ltd.

Trading Symbol: BGNE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 9,290 shares
Current Value: $333,697
Latest Transaction: Jun 19 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Thomas Malley in BeiGene, Ltd.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BGNE, CGRB, KNSA, KURA, OVAS, GEVA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 19 2020	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Option Exercise	A	13.42	45,383	609,040	45,383
Jun 07 2019	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Option Exercise	A	9.23	64,610	596,350	64,610
Jun 08 2018	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Option Exercise	A	16.15	17,442	281,688	17,442
Jun 08 2018	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Grant	A	0.00	9,290	0	9,290	0 to 9.3 K
Jun 06 2017	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Option Exercise	A	3.16	169,988	537,162	169,988
Nov 28 2016	BGNE	BeiGene, Ltd.	Malley Thomas	Director	Buy	P	32.00	30,000	960,000	30,000	0 to 30 K

Page: 1